Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00166348|
Recruitment Status : Completed
First Posted : September 14, 2005
Last Update Posted : January 20, 2010
|Condition or disease||Intervention/treatment|
|Brain Injuries||Behavioral: Cognitive Group Therapy|
This research study will look at the outcome benefits of providing cognitive rehabilitation, utilizing the group process. Criteria for selecting the appropriate participants, group format and structure, as well as use of standardized assessments. The assessments used: Three Step Calendar Approach, (Sohlberg and Mateer) Satisfaction With Life scale (SWLS), Community Integration Questionnaire (CIQ), Independent Living Scale, and the Vocational Independence Scale. The group setting provides an atmosphere to work on building communication skills through peer feedback and to develop psychological coping strategies. Techniques such as the problem solving format and a calendar system. Analysis and outcomes of 17 past group participants were analyzed supporting cognitive rehabilitation in the group setting.
Of the 20 participants, 3 chose not to be included.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Efficacy of Group Based Cognitive Rehabilitation Following Acquired Brain Injury|
|Study Start Date :||March 2003|
|Primary Completion Date :||February 2007|
|Study Completion Date :||March 2008|
- provide evidence which supports cognitive therapy in a group setting
- less labor intensive
- cost effectiveness
- peer feedback is effective
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00166348
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Merri L Vitse||Mayo Clinic|